Clinical Trial Update: Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients. [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates randomized use of risedronate to prevent bone loss in renal transplant recipients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Osteodystrophy

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Renal Transplant Osteodystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-01